Medicare Advantage Star Ratings Continue to Fade but Market Marches On Into 2025

Looking to drive meaningful change in the health care ecosystem? Look to the Deloitte Health Equity Institute. Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss Medicare open enrollment, the newly-announced 2025 Medicare Advantage and Part D Star Ratings, and how large insurance companies may be scaling back Medicare Advantage product offerings. Check out the October 2024 issue of Health Affairs. RSVP for our upcoming Journal Club Event on 10/21 featuring an examination on the timing of new drug launches in low-, middle-, and high-income markets from 1982 to 2024. Check out our 2024 Election Collection available from Health Affairs with featured paywalled content made available for $39.95. In preparation of our November 2024, explore a new ahead-of-print article from Gary Claxton and coauthors on employer strategies for covering GLP-1 agonists, mental health, substance use, and other family benefits as employer-sponsored health insurance premiums continue to increase. Related Articles:PRESS RELEASE FROM CMS NEWSROOM: 2025 Medicare Advantage and Part D Star RatingsMedicare Advantage Supplemental Benefits: Origins, Evolution, And Issues For Policy Making (Health Affairs Forefront)